Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.62

+0.1%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (8538)	10/7/1997 7:27:00 AM
From: DrJerry	of 32384

Andy- the use of bromocriptine at present is limited because of side effects- the most common setting is pituitary tumors associated with abnormal prolactin levels- its use in Parkinsonism is not very common- for intended use with diabetes I would have major reservations namely because as an ergot derivative there would be strong warnings for patients with coronary disease (because of propensity to provoke coronary spasm) and hypertension (because of both hypo and hypertensive episodes associated with the drug). Since diabetics in large part have both disease entities I would see a limited market.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next